SEELQ — Seelos Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
U.S. STOCKS ON THE MOVE-General Electric, Boeing, Vertex Energy, Beyond Meat
Seelos Therapeutics: Rises on European orphan drug tag for ALS treatment
Brief: Seelos Therapeutics Receives European Orphan Drug Designation For Sls-005 (Trehalose) In Amyotrophic Lateral Sclerosis (Als)
U.S. STOCKS ON THE MOVE-Tesla, VBI Vaccines, Ralph Lauren, Virgin Galactic
Seelos Therapeutics slips on $60 mln equity raise
Brief: Seelos Therapeutics Announces Pricing Of $60 Mln Public Offering Of Common Stock
Brief: Seelos Therapeutics Announces Proposed Public Offering Of Common Stock
Seelos Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Seelos Therapeutics Receives Positive EMA Opinion On Orphan Drug Designation For SLS-005 In Amyotrophic Lateral Sclerosis
Brief: Seelos Therapeutics Announces Strategic Device Partnership With AptarGroup Inc
Seelos Therapeutics: BTIG sees potential in lead drug, starts with "buy"
Brief: Seelos Therapeutics Announces Completion Of Open-Label Patient Enrollment Of Proof Of Concept Study Of SLS-002
Brief: Seelos Announces Amendment Of SLS-002 Agreement To Repurchase Significant Portion Of Royalties For SLS-002
Brief: Seelos Therapeutics Announces Issuance Of A Patent For Trehalose (SLS-005) In Australia
Brief: Seelos Therapeutics Announces Its Inclusion In The First Psychedelic Exchange Traded Fund (ETF)
Seelos Therapeutics falls on deep-discounted stock offering
Brief: Seelos Therapeutics Announces Pricing Of $31.25 Million Public Offering Of Common Stock
Brief: Seelos Therapeutics Announces Proposed Public Offering Of Common Stock
Brief: Seelos Therapeutics Receives A Notice Of Allowance In Japan For SLS-005 (Trehalose)